Table 3.
Relationship between each gene and clinical outcomes in cagA-positive cases in Colombia
| Gastritis | DU | GC | ||||||
|---|---|---|---|---|---|---|---|---|
| n | 44 | 27 | P | 45 | P | |||
| mean age | 51.0 ± 15.3 | 47.2 ± 14.3 | 0.51 | 57.6 ± 14.3 | 0.02 | |||
| male | 19 | (43.2%) | 13 | (46.4%) | 0.68 | 31 | (67.4%) | 0.02 |
| vacA s1 | 42 | (95.5%) | 24 | (85.7%) | 0.27 | 42 | (91.3%) | 0.51 |
| vacA m1 | 33 | (75.0%) | 19 | (67.9%) | 0.66 | 36 | (78.3%) | 0.37 |
| hp0967 | 24 | (54.5%) | 12 | (42.9%) | 0.40 | 27 | (58.7%) | 0.60 |
| jhp0045 | 5 | (11.4%) | 7 | (25.0%) | 0.10 | 14 | (30.4%) | 0.02 |
| jhp0046 | 8 | (18.2%) | 7 | (25.0%) | 0.43 | 16 | (34.8%) | 0.06 |
| jhp0951 | 25 | (56.8%) | 19 | (67.9%) | 0.25 | 27 | (58.7%) | 0.76 |
DU, duodenal ulcer; GC, gastric cancer
*P value was compared with gastritis